Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule

SAN ANTONIO, TX / ACCESS Newswire / September 22, 2026 / Valion Bio, Inc. (Nasdaq:VBIO) ("Valion" or the "Company) announced today that it has received formal written notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).

Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum closing bid price of $1.00 per share. Valion satisfied the requirement by maintaining a closing bid price of at least $1.00 per share for the requisite period. Accordingly, Nasdaq's Listing Qualifications Staff has determined that the Company has regained compliance, and the matter is now closed.